TY - JOUR
T1 - Retinoids exacerbate rat liver fibrosis by inducing the activation of latent TGF-β in liver stellate cells
AU - Okuno, Masataka
AU - Moriwaki, Hisataka
AU - Imai, Shoko
AU - Muto, Yasutoshi
AU - Kawada, Norifumi
AU - Suzuki, Yasuhiro
AU - Kojima, Soichi
PY - 1997/10
Y1 - 1997/10
N2 - Liver stellate cells (SCs) play central roles in both the storage of retinol and the development of liver fibrosis. The present study is aimed to understand the mechanism by which retinoic acid (RA, an active metabolite of retinol) enhances hepatic fibrosis in rats. We tested the effect of 9-cis-RA on several aspects in vitro rat SC cultures, including the activity of cellular plasminogen activator (PA), messenger RNA (mRNA), and protein levels of transforming growth factor-β (TGF-β) MRNA level of type-I procollagen, and the activity of type-I collagenase. Employing the rat liver fibrosis model produced by porcine serum, we also estimated the effect of oral administration of a stable RA analog on the progression of the fibrosis, as well as on hepatic TGF-β contents. In vitro SC cultures, 9-cis-RA enhanced cellular PA and plasmin levels thereby induced plasmin-mediated activation of latent TGFβ. Active TGF-β generated self-stimulated its synthesis as well as that of collagen and suppressed the production of collagenase in an autocrine manner. In in vivo rat models, an RA analog accelerated the porcine serum-induced fibrosis by enhancing TGF-β contents and, thus, collagen levels in the liver, although the RA analog alone was not fibrogenic. These results suggest that RA exacerbated liver fibrosis, at least in part, by inducing the activation and production of latent TGFβ in liver SCs.
AB - Liver stellate cells (SCs) play central roles in both the storage of retinol and the development of liver fibrosis. The present study is aimed to understand the mechanism by which retinoic acid (RA, an active metabolite of retinol) enhances hepatic fibrosis in rats. We tested the effect of 9-cis-RA on several aspects in vitro rat SC cultures, including the activity of cellular plasminogen activator (PA), messenger RNA (mRNA), and protein levels of transforming growth factor-β (TGF-β) MRNA level of type-I procollagen, and the activity of type-I collagenase. Employing the rat liver fibrosis model produced by porcine serum, we also estimated the effect of oral administration of a stable RA analog on the progression of the fibrosis, as well as on hepatic TGF-β contents. In vitro SC cultures, 9-cis-RA enhanced cellular PA and plasmin levels thereby induced plasmin-mediated activation of latent TGFβ. Active TGF-β generated self-stimulated its synthesis as well as that of collagen and suppressed the production of collagenase in an autocrine manner. In in vivo rat models, an RA analog accelerated the porcine serum-induced fibrosis by enhancing TGF-β contents and, thus, collagen levels in the liver, although the RA analog alone was not fibrogenic. These results suggest that RA exacerbated liver fibrosis, at least in part, by inducing the activation and production of latent TGFβ in liver SCs.
UR - http://www.scopus.com/inward/record.url?scp=0030755313&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030755313&partnerID=8YFLogxK
U2 - 10.1002/hep.510260417
DO - 10.1002/hep.510260417
M3 - Article
C2 - 9328313
AN - SCOPUS:0030755313
SN - 0270-9139
VL - 26
SP - 913
EP - 921
JO - Hepatology
JF - Hepatology
IS - 4
ER -